Skip to content
Methodology
All entries for: Calluna Pharma AS
October 24, 2025
Calluna Pharma AS
Orphan Drug Designation
FDA orphan drug designation: treatment of idiopathic pulmonary fibrosis
Disease Area:
Rare Diseases
Source
Scroll to Top
